Summary
Peripheral α-adrenoceptor stimulation was tested by means of hypertensive effects of the drugs following i.v. injection in spinal rats. Naphazoline (NP), oxymetazoline (OM), St 91-2-(2,6-diethylphenylimino)-2-imidazolidine- and St 1697-2-(2-ethyl, 6-methylphenylimino)-2-imidazolidine-were 3 to 5 times more potent in this respect than clonidine (CLON) whereas St 363-2-(2,4-dichlorophenylimino)-2-imidazolidine-and xylazine (XY) exerted only approx. 1/20 the effect of that of clonidine. Sympathoinhibitory activity after i.v. injection was tested by the bradycardiac effect in vagotomized rats; St 1697, St 363 and XY were active, approx. 1/10–1/30 of CLON, whereas NP, OM and St 91 were inactive.
However, following intracisternal (i.ci.) injection all test substances exerted actions of cardiovascular depression, typical for clonidine: (1) in dogs with blocked β-adrenoceptors, the drugs facilitated the vagally mediated cardiodepressor reflex in response to baroreceptor stimulation by i.v. injection of angiotensin; (2) in dogs treated with atropine and in (3) vagotomized cats (only NP, OM and St 363) a long lasting decrease in heart rate was observed. Some of the experiments were complicated by increases in blood pressure, due to the “leakage” of small amounts of the highly vasopressor active drugs, from the cisternal spaces into the peripheral circulation. The majority of results indicated, that the central cardiovascular depressor effects of the tested drugs depend on their α-adrenoceptor stimulating potency and on their ability to penetrate from cerebrospinal fluid or from the blood to cardiovascular centers. Relationships between the ability for penetration and the lipoid affinity are discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Antonaccio, M. J., Robson, R. D., Kerwin, L.: Evidence for increased vagal tone and enhancement of baroreceptor reflex activity after xylazine (2-(2,6-dimethyl-phenylamino)-4H-5,6-dihydro-1,3-thiazine) in anesthetized dogs. Europ. J. Pharmacol. 23, 311–315 (1973)
Autret, A. M., Schmitt, H., Fénard, S., Péillot, N.: Comparison of haemodynamic effects of α-sympathomimetic drugs. Europ. J. Pharmacol. 13, 208–217 (1971)
Hoefke, W., Kobinger, W.: Pharmakologische Wirkungen des 2-(2,6 Dichlorphenyl-amino)-2-imidazolinhydrochlorids, einer neuen antihypertensiven Substanz. Arzneimittel-Forsch. (Drug Res.) 16, 1038–1050 (1966)
Hoefke, W., Kobinger, W., Walland, A.: Relationship between activity and structure in derivatives of clonidine. Arzneimittel-Forsch. (Drug Res.) 25, 786–793 (1975)
Kobinger, W.: Über den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit Imidazolstruktur. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 258, 48–58 (1967)
Kobinger, W.: Medicinal chemistry related to the central regulation of blood pressure. II. Pharmacological part. Proc. IV Int. Symp. Med. Chemistry, Main lectures, Ed. J. Maas, pp. 107–120. Amsterdam: Elsevier Scientific Publishing Comp. 1974
Kobinger, W., Pichler, L.: Localisation in the CNS of adrenoceptors which facilitate a cardioinhibitory reflex. Naunyn-Schmiedeberg's Arch. Pharmacol. 286, 371–377 (1975)
Kobinger, W., Walland, A.: Kreislaufuntersuchungen mit 2-(2,6-Dichlorphenylamino)-2-imidazolinhydrochlorid. Arzneimittel-Forsch. (Drug Res.) 17, 202–300 (1967)
Kobinger, W., Walland, A.: Involvement of adrenergic receptors in central vagus activity. Europ. J. Pharmacol. 16, 120–122 (1971)
Kobinger, W., Walland, A.: Evidence for a central activation of a vagal cardiodepressor reflex by clonidine. Europ. J. Pharmacol. 19, 203–209 (1972a)
Kobinger, W., Walland, A.: Facilitation of vagal reflex bradycardia by an action of clonidine on central α-receptors. Europ. J. Pharmacol. 19, 210–217 (1972b)
Kroneberg, G., Oberdorf, A., Hoffmeister, F., Wirth, W.: Zur Pharmakologie von 2-(2,6-Dimethylphenylamino)-4H-5,6-dihydro-1,3-thiazin (Bayer 1470), eines Hemmstoffes adrenergischer und cholinergischer Neurone. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 256, 257–288 (1967)
Leo, A., Hansch, C., Elkins, D.: Partition coefficients and their uses. Chem. Rev. 71, 525–616 (1971)
Mujic, M., van Rossum, J. M.: Comperative pharmacodynamics of sympathomimetic imidazolines; studies on intestinal smooth muscle of the rabbit and the cardiovascular system of the cat. Arch. int. Pharmacodyn. 155, 432–449 (1965)
Pook, K.-H., Stähle, H., Daniel, H.: Strukturuntersuchungen an 2-(Arylamino)-imidazolidinen und 2-(Arylamino)imidazolinen mit Hilfe der Protonen- und Kohlenstoff-13-Resonanz. Chem. Ber. 107, 2644–2657 (1974)
Schmitt, H., Fénard, S.: Effects des substances sympathomimétiques sur les centres vasomoteurs. Arch. int. Pharmacodyn. 190, 229–240 (1971)
Schmitt, H., Schmitt, H., Fénard, S.: Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Europ. J. Pharmacol. 14, 98–100 (1971)
Struyker-Boudier, H., Smeets, G., Brower, G., van Rossum, J.: Central and peripheral α-adrenergic activity of imidazoline derivatives. Life Sci. 15, 887–899 (1974)
Wermuth, C. G., Schwartz, J., Leclerc, G., Garnier, J. P., Rouot, B.: Conformation de la clonidine et hypothèses sur son interaction avec un récepteur α-adrénergique. Chim. Thér. 1, 115–116 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kobinger, W., Pichler, L. Investigation into some imidazoline compounds, with respect to peripheral α-adrenoceptor stimulation and depression of cardiovascular centers. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 175–191 (1975). https://doi.org/10.1007/BF00500048
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00500048